Ac-GLARS-NH2

Ref. 3D-PP48041

Informations sur le produit

• Nom: Ac-GLARS-NH2

Description

Peptide Ac-GLARS-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-GLARS-NH2 include the following: Polysaccharides for Bacterially Triggered System in Colon Targeting P Soni, GP Chaudhary, LK Soni - Current Research in , 2015 - crpsonline.comhttp://www.crpsonline.com/index.php/crps/article/view/144 Entire regularization path for sparse nonnegative interaction model M Takayanagi, Y Tabei , H Saigo - 2018 IEEE International , 2018 - ieeexplore.ieee.orghttps://ieeexplore.ieee.org/abstract/document/8594977/ Sparse nonnegative interaction models M Takayanagi, Y Tabei , E Suzuki , H Saigo - IEEE Access, 2021 - ieeexplore.ieee.orghttps://ieeexplore.ieee.org/abstract/document/9493878/ Thermosensitive mutants of Escherichia coli K-12 altered in the catalytic subunit and in a regulatory factor of the glutamy-transfer ribonucleic acid synthetase J Lapointe , G Delcuve - Journal of bacteriology, 1975 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jb.122.2.352-358.1975 Association of lower circulating Spexin levels with higher body mass indices and glucose metabolic profiles in adult subjects in Egypt ES Albeltagy , NM Abd Elbaky - Human Nutrition & Metabolism, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2666149721000190 An update on galanin and spexin and their potential for the treatment of type 2 diabetes and related metabolic disorders DM Gallagher, FPM O'Harte , N Irwin - Peptides, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978123001614 Emerging oral controlled-release technology for optimal therapy BJ Lee , JB Park - 2013 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.4155/ebo.13.376

• Marque: Biosynth